HROW
Harrow Health, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$38.54
+0.73%Forward multiples
Based on analyst estimates
- P/E forward
- 30.48x
- P/E 2026E
- —
- P/E 2027E
- 17.03x
- P/E 2028E
- 9.26x
- P/S forward
- 3.24x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 95.05x
- Price / sales
- 5.24x
- Price / cash flow
- 231.09x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 6.03x
- EV / EBITDA
- 370.57x
- EV / EBIT
- 291.40x
- Market cap
- $1.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026